Babies born with a narrowed blood vessel now have a device specifically designed for them, thanks to research conducted at ...

Summary: The use of balloon angioplasty with or without coronary artery stenting is limited by the phenomenon of in-stent restenosis (ISR). Until very recently, most efforts to overcome ISR had ...

The company's drug-eluting stent technologies have been developed through a technological collaboration with the prestigious ...

Industrial Analysis of Coronary Stent in India value of over USD 1,213.5 million by 2033 anticipated expansion is supported ...

The global coronary stent market size is anticipated to grow from USD 9.48 billion to USD 13.75 billion in 10 years. The market will experience rapid growth due to the increasing adoption of minimally ...

Renata Medical announced the first completed implantation of its Minima growth stent for young children after winning FDA ...

A study has found that sirolimus-coated balloons vs thin drug-eluting stents in in-stent restenosis show similar favorable clinical outcomes.

SpectraWAVE has raised $50 million to support its approach to imaging the insides of clogged, plaque-filled blood vessels. | ...

Among patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent (DES) implantation, there was no difference with respect to ischaemic outcomes or major bleeding ...

Citation: Examining aspirin interruption or continuation in patients with coronary stents undergoing non-cardiac surgery (2024, September 2) retrieved 17 September 2024 from https://medicalxpress ...

Michael Matson, an analyst from Needham, maintained the Buy rating on Merit Medical Systems (MMSI – Research Report). The associated ...